Answers are grounded in this paper and cite their sources.
This translational report on the current field of emerging cell therapy and tissue engineering therapies includes the challenges and opportunities to accelerate clinical translation in regenerative medicine. Translation of regenerative medicine refers to the transfer from bench (proof-of-concept) to bedside (clinical trials), and finally commercialization. Regenerative medicine therapies have the capacity to replace, repair, and regenerate cells, tissues, and organs to restore normal function in the body. These emerging therapies are shifting the paradigm from treatment-based to cure-based therapies.
No takes yet. Share an insight, caveat, or question.
JG Allickson (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: